“This decision (introduction of vaccine for children) needs to be taken very carefully. We do not want to rush into vaccinating children. Children are the future of our country. The government will seek expert opinion and comply, “Mandavia said.
The minister’s remarks indicate that the decision to vaccinate children is not a one-size-fits-all decision. The government noted that CERO surveys conducted by the Center and the states have also shown a high prevalence of antibodies in adults and in children who have not been vaccinated. This has encouraged officials to think more about their decision to vaccinate their children
India has ample vaccines and Mandavia emphasized the need to support other countries with medical products and services. “We will supply vaccines to the world in the future and it will be a low cost vaccine – not 15 15-18 but 3-4 3-4 – and people around the world will accept it. We can help poor countries like this. Indian culture,” Mandavia said.
A total of 31 million doses of Covid-Ticker will be delivered in November, and companies are constantly increasing production capacity. More companies are set to start vaccine production in India and production will increase further in the coming months to meet global demand, he added.
Currently, the government is focusing on maximizing coverage of first and second dose vaccines. Of the 160 million unused doses of the covid vaccine available in the States and Union Territories, 79% of the eligible population are covered with the first dose, with 38% receiving both. More than 12 million people are there to give them a second dose.
While the center is confident of meeting the December deadline for full coverage of the adult population, Mandavia says it is pressuring states to ensure early results.
The Health Minister further said that the government has used the opportunity to enhance the health infrastructure and facilities across the country so that it is efficiently prepared to deal with any such epidemic or health emergency in the future.